Diabetes drug linked to Post-Surgery complication? new study investigates

NCT ID NCT07127406

First seen Jun 26, 2026 · Last updated Jun 26, 2026

Summary

This observational study tracks 300 adults with diabetes who take SGLT-2 inhibitors and are recovering from surgery in the intensive care unit. Researchers want to find out how often a rare type of diabetic ketoacidosis (called euglycemic DKA) occurs after surgery. The goal is to identify risk factors and improve patient safety, but this study does not test any new treatment.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to

If this study succeeds, it could help doctors better understand the risk of a rare but serious complication after surgery in patients taking SGLT-2 inhibitors for diabetes.

What could go wrong

This is an observational study, not a treatment trial, so it won't test any new drug or therapy. It only looks at what happens in a specific hospital setting, so results may not apply to all patients.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for DIABETES MELLITUS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

diabetes mellitus diabetic ketoacidosis

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Kocaeli City Hospital

    Kocaeli, İzmit, 41060, Turkey (Türkiye)